1. Thiery M. Intrauterine contraception: from silver ring to intrauterine contraceptive implant. Eur J Obstet Gynecol Reprod Biol. 2000; 90:145–52.
Article
2. Lin X, Wei M, Li TC, Huang Q, Huang D, Zhou F, et al. A comparison of intrauterine balloon, intrauterine contraceptive device and hyaluronic acid gel in the prevention of adhesion reformation following hysteroscopic surgery for Asherman syndrome: a cohort study. Eur J Obstet Gynecol Reprod Biol. 2013; 170:512–6.
Article
3. Stoddard A, McNicholas C, Peipert JF. Efficacy and safety of long-acting reversible contraception. Drugs. 2011; 71:969–80.
Article
4. Fadiloglu S, Dilbaz B, Fadiloglu E, Dilbaz S. Relationship between copper IUD complications and ultrasonographic findings. Arch Gynecol Obstet. 2018; 297:989–96.
Article
5. Mutlu I, Demir A, Mutlu MF. Can uterine artery Doppler parameters predict copper intrauterine device-induced side effects? Eur J Contracept Reprod Health Care. 2013; 19:51–6.
Article
6. Rezk M, Elkelani O, Gaber W, Shawky M. Pre-insertion uterine artery Doppler indices may predict intrauterine contraceptive device-related heavy menstrual bleeding. Middle East Fertil Soc J. 2018; 23:496–500.
Article
7. Mohamed RS, Abdel Hakim SF. Uterine artery doppler as predictor of side effects in copper intrauterine device users. Al-Azhar Assiut Med J. 2015; 13:63–71.
8. Larsson B. Reply to Drs. Salgo and Oster. Am J Obstet Gynecol. 1977; 128:921–2.
Article
9. Gbarbea E. Contraception: past, present, and future [dissertation]. [Boston]: Boston University School of Medicine;2015. 1–58.
11. Adeyemi-Fowode O, Bercaw-Pratt J. Intrauterine devices: effective contraception with noncontraceptive benefits for adolescents. J Pediatr Adolesc Gynecol. 2019; 32:S2–6.
Article
12. Bousfield GR, May JV, Davis JS, Dias JA, Kumar TR. In vivo and in vitro impact of carbohydrate variation on human follicle-stimulating hormone function. Front Endocrinol (Lausanne). 2018; 9:216.
Article
13. Fouda UM, Yossef D, Gaafar HM. Uterine artery blood flow in patients with copper intrauterine device-induced abnormal uterine bleeding. Middle East Fertil Soc J. 2010; 15:168–73.
Article
14. Mansour GM, Hussein SH, Mohammed HF, El Mekkawy SF, Akl SA, Abd El Dayem AA. Can we predict menorrhagia with intrauterine contraceptive device (IUCD) insertion? Open J Obstet Gynecol. 2017; 7:753–66.
Article
15. Järvelä I, Tekay A, Jouppila P. The effects of a copper-intrauterine device on the uterine artery blood flow in regularly menstruating women. Hum Reprod. 1998; 13:1841–5.
16. El-Mazny A, Abou-Salem N, Elshenoufy H. Three-dimensional power Doppler study of endometrial and subendometrial microvascularization in women with intrauterine device-induced menorrhagia. Fertil Steril. 2013; 99:1912–57.
Article
17. Jiménez MF, Arbo E, Vetori D, de Freitas FM, Cunha-Filho JSL. The effect of the levonorgestrel-releasing intrauterine system and the copper intrauterine device on subendometrial microvascularization and uterine artery blood flow. Fertil Steril. 2008; 90:1574–8.
Article